Clinical Trials Logo

Clinical Trial Summary

Non-invasive brain stimulation can both study and potentially treat neurological disorders. Transcranial direct-current stimulation (tDCS) is an emerging safe and tolerability form of stimulation and has been used increasingly over the last decade.

The purpose of this research is to see if two different types of tDCS can improve motor function in healthy children. tDCS has been shown to safely enhance hand motor function in healthy adults, and those that have suffered stroke and other conditions. Recently the investigators demonstrated that tDCS may enhance hand motor function in healthy children, however, how it does so is unknown. In addition to assessing changes in motor function when tDCS is given during motor skill training, the investigators will perform various tests before and after stimulation to understand the changes that happen in the brain accompanying motor skill learning and brain stimulation.

The investigators hypothesize that there will be an accelerated acquisition of motor skill, when training is paired with conventional anodal tDCS, HD-tDCS, or sham tDCS.


Clinical Trial Description

Background & rationale: Plasticity may be enhanced in the developing brain but mechanisms are poorly understood. Brain stimulation technologies such as transcranial direct-current stimulation (tDCS) modulate motor cortex excitability and plasticity. Studies by our group and others suggest that neuromodulation trials with tDCS are both safe and feasible in children. Recently the investigators demonstrated that conventional tDCS can enhance motor learning in healthy children. Additionally, recent advances in high-definition tDCS (HD-tDCS) have presented an opportunity to focally stimulate regions of the brain. HD-tDCS has not been investigated to date in children.

Establishing an ability of tDCS to enhance motor learning has therapeutic implications for children with motor disabilities. Perinatal stroke is the leading cause of hemiparetic cerebral palsy and most survivors suffer lifelong physical disability. Emerging models from our lab and others have defined central therapeutic targets whereby brain stimulation may enhance motor learning and function. Understand the effects of tDCS on motor learning, and it's underlying changes within the brain, is essential to advancing such interventions.

Research question & objectives: Here the investigators propose to characterize the effects of tDCS on motor learning in healthy children. The primary objective of this study is to determine changes in acquisition of motor skill, when training is paired with conventional anodal tDCS, HD-tDCS, or sham tDCS. Multiple secondary objectives will describe biochemical and sensorimotor changes in the brain that take place during motor learning paired with tDCS. Secondary objectives will also assess the safety of HD- tDCS in healthy children.

Ethics: This study has been approved by the University of Calgary Research Ethics Board.

Design: Randomized, double blind, sham-controlled trial to evaluate the ability of tDCS and HD-tDCS to enhance motor learning.

Methods: Children will be recruited through the Healthy Infants and Children Clinical Research Program.

The training task will consists of performing the Purdue Pegboard Test (PPTL) with their left hand. This simple motor learning task is a well-validated task for complex, functionally relevant motor learning. The PPTL has demonstrated good sensitivity to change in both healthy and disease motor learning studies in adults and school-aged children. The PPTL will be performed over five consecutive days to monitor motor learning.

Children will attend the Alberta Children's Hospital Non-Invasive Brain Stimulation Laboratory. Subjects will be randomized to one of three stimulation groups (sham tDCS, conventional anodal tDCS, HD-tDCS). Baseline measures will be performed, including: magnetic resonance neuroimaging (anatomical imaging, functional neuroimaging and magnetic resonance spectroscopy), transcranial magnetic stimulation neurophysiology (motor mapping of the left and right motor cortex), sensorimotor functional changes assessed using the Kinesiological Instrument for Normal and Altered Reaching Movements (KINARM; arm positioning matching, kinesthesia, visually guided reaching, and object hit task), motor function changes (PPT, Jebsen-Taylor Test, Serial Reaction Time Task), and sensory discrimination measures (amplitude discrimination, temporal order judgment, temporal order judgment task, duration discrimination task, duration discrimination with confound, and single site adaptation task.

Following baseline measures, subjects will be seating in a comfortable chair with the PPTL test in front of them on a table. Participant randomized to sham or conventional anodal tDCS will be fitted with two 25cm2 electrodes (anode over the right primary motor cortex, cathode over the contralateral supraorbital area) or an EEG cap containing four small circular electrode (HD-tDCS, 1 anode centered over the right primary motor cortex, 4 cathodes surround the anode in a ring-like fashion). Three pre-intervention trials of the PPTL will be performed. All subjects will then have the tDCS ramped up to 1milliamp over 45 seconds. After 120 seconds the current will either be ramped down to 0milliamp (sham tDCS) or continue for a total of 20 minutes. The PPTL will be performed 5, 10, and 15 minutes following stimulation commencement, and after stimulation has ended (3 repetitions per time point). A tDCS safety and tolerability questionnaire will then be completed.

The same tDCS-treatment, PPTL training and safety and tolerability questionnaires will be performed over the next three consecutive days. On study day 5 participants will again repeat PPTL training paired with tDCS-treatment. Following tDCS and PPTL training, magnetic resonance neuroimaging, transcranial magnetic stimulation neurophysiology, sensorimotor functional changes, motor function changes, and sensory discrimination measures will be repeated to assess changes induced by motor learning and tDCS.

Participants will return six weeks following training, where magnetic resonance neuroimaging, transcranial magnetic stimulation neurophysiology, sensorimotor functional changes, motor function changes, and sensory discrimination measures will be repeated to assess long-term changes.

Data analysis: All outcome variables will be compared across the three intervention groups (sham tDCS, conventional tDCS, HD- tDCS) using a two-way repeated measures ANOVA with appropriate post-hoc analysis. The repeated measures ANOVA will distinguish the influence of intervention (stimulation type) and time (baseline, post-training, 1 month post- training). Pearson's correlations will be performed between the primary outcome measure and secondary outcome measures. Secondary statistical analysis will be performed as warranted. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03193580
Study type Interventional
Source University of Calgary
Contact
Status Completed
Phase N/A
Start date July 1, 2017
Completion date August 30, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1